Naloxone does not antagonize PCP-induced stimulation of the pituitary-adrenal axis in the rat.
暂无分享,去创建一个
[1] M. Carroll. A quantitative assessment of phencyclidine dependence produced by oral self-administration in rhesus monkeys. , 1987, The Journal of pharmacology and experimental therapeutics.
[2] W. D. Wessinger. Behavioral dependence on phencyclidine in rats. , 1987, Life sciences.
[3] T. Kameyama,et al. Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine. , 1987, European journal of pharmacology.
[4] T. Takao,et al. Effects of (D-ala2, met5)-enkephalinamide and naloxone on ACTH and corticosterone secretion. , 1986, Endocrinologia japonica.
[5] H. Kim,et al. Effects of kappa opiate agonists on neurochemical and neuroendocrine indices: evidence for kappa receptor subtypes. , 1986, Life sciences.
[6] T. O'donohue,et al. Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions. , 1986, European journal of pharmacology.
[7] R. Poland,et al. The effects of the acute administration of phencyclidine hydrochloride (PCP) on the release of corticosterone, growth hormone and prolactin in the rat. , 1986, Life sciences.
[8] T. Kameyama,et al. Involvement of opioid receptors in hypo- and hyperthermic effects induced by phencyclidine in mice. , 1986, Journal of pharmacobio-dynamics.
[9] D. Jezova. Stimulation of ACTH release by naloxone: central or peripheral action? , 1985, Life sciences.
[10] J. W. Spain,et al. Continuous intravenous infusion of phencyclidine in unrestrained rats results in the rapid induction of tolerance and physical dependence. , 1985, The Journal of pharmacology and experimental therapeutics.
[11] N. Benowitz,et al. Altered methadone pharmacokinetics in methadone-maintained pregnant women. , 1985, The Journal of pharmacology and experimental therapeutics.
[12] R. Poland,et al. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3. , 1985, The Journal of pharmacology and experimental therapeutics.
[13] T. Nabeshima,et al. Attenuation of pharmacological effects and increased metabolism of phencyclidine in morphine tolerant mice. , 1984, European journal of pharmacology.
[14] M. Leid,et al. Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes. , 1984, Life sciences.
[15] A. Tomie,et al. Effects of SKF-10047 in the phencyclidine-dependent rat: evidence for common receptor mechanisms. , 1983, Drug and alcohol dependence.
[16] D. B. Vaupel,et al. Naltrexone fails to antagonize the σ effects of PCP and SKF 10,047 in the dog , 1983 .
[17] R. Zukin,et al. Specific Binding of [3H] phencyclidine in rat central nervous tissue: further characterization and technical considerations , 1983, Brain Research.
[18] S. Feldman,et al. Effects of naloxone on basal and stress-induced ACTH and corticosterone secretion in the male rat - site and mechanism of action , 1982, Brain Research.
[19] S. D. Glick,et al. Naloxone antagonism of the thermoregulatory effects of phencyclidine. , 1982, Science.
[20] H. Shannon. Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats. , 1982, The Journal of pharmacology and experimental therapeutics.
[21] J. Woods,et al. Stereospecific binding of 3H-phencyclidine in brain membranes. , 1982, Life sciences.
[22] R. Zukin,et al. EFFECTS OF PHENCYCLIDINE AND ITS DERIVATIVES ON ENTERIC NEURONES , 1982, British journal of pharmacology.
[23] R. Palmour,et al. Naloxone and phencyclidine: Interacting effects on the limbic system and behavior , 1981, Physiology & Behavior.
[24] Y. Sarne,et al. On the opioid nature of phencyclidine and its 3-hydroxy derivative. , 1981, European journal of pharmacology.
[25] S. Cohen,et al. Receptor binding and antinociceptive properties of phencyclidine opiate-like derivatives. , 1981, European journal of pharmacology.
[26] R. Rawson,et al. Withdrawal from chronic phencyclidine (PCP) dependence with desipramine. , 1981, The American journal of psychiatry.
[27] R. Rubin,et al. Neonatal dexamethasone administration. I. Temporary delay of development of the circadian serum corticosterone rhythm in rats. , 1981, Endocrinology.
[28] M. Fauman,et al. Chronic phencyclidine (PCP) abuse: a psychiatric perspective. , 1980, Journal of psychedelic drugs.
[29] R. Eisenberg. Effects of naloxone on plasma corticosterone in the opiate-naive rat. , 1980, Life sciences.
[30] P. Pyati,et al. Inhibition of drug metabolism by chronically administered naltrexone. , 1979, Life sciences.
[31] M. Lazdunski,et al. Interaction of phencyclidines with the muscarinic and opiate receptors in the central nervous system , 1978, Brain Research.
[32] T. F. Murray. The effects of phencyclidine on operant behavior in the rat: biphasic effect and tolerance development. , 1978, Life sciences.
[33] F. Bloom,et al. beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. , 1977, Science.